Targeting CDC42 reduces skeletal degeneration after hematopoietic stem cell transplantation.
Landspersky T, Stein M, Saçma M, Geuder J, Braitsch K, Rivière J, Hettler F, Romero Marquez S, Vilne B, Hameister E, Richter D, Schönhals E, Tuckermann J, Verbeek M, Herhaus P, Hecker JS, Bassermann F, Götze KS, Enard W, Geiger H, Oostendorp RAJ, Schreck C.
Landspersky T, et al. Among authors: richter d.
Blood Adv. 2024 Oct 22;8(20):5400-5414. doi: 10.1182/bloodadvances.2024012879.
Blood Adv. 2024.
PMID: 39159429
Free PMC article.